腹腔镜与开腹肝切除术治疗肝内胆管细胞癌患者疗效与安全性研究

doi:10.3969/j.issn.1672-5069.2022.02.031

摘要/Abstract

摘要： 目的比较腹腔镜肝切除术(LLR)与开腹肝切除术(OLR)治疗肝内胆管细胞癌(ICC)患者的疗效与安全性。方法 2015年1月～2018年6月我院诊治的ICC患者74例,其中32例接受LLR手术,另42例接受OLR手术。随访3年。结果两组年龄、性别、腹部手术史、血清CA19-9和CEA水平、神经侵犯、微血管侵犯、肿瘤低分化、肿瘤直径和淋巴结肿大等差异无统计学意义(P>0.05);LLR组术中失血量、手术切口长度、肝门阻断、术后住院日、输血和胃肠道功能恢复时间分别为325(250,475)ml、5(3.5,6.5)cm、9例(28.1%)、7(5,12)d、2例(6.2%)和2(2,4)d,与OLR组【分别为500(375,750)ml、20.5(17.0,25.0)cm、31例(73.8%)、10(7,15)d、7例(16.7%)和4(3,6)d】比,差异具有统计学意义(P<0.05),而两组1 a生存率(81.2%对76.2%)和3 a生存率(46.8%对33.3%)无显著性差异(P>0.05);术后,两组均未发生严重并发症。结论在当前情况下,采取OLR或LLR手术治疗ICC患者均可获得较好的治疗效果,且并发症较少。各地可根据肿瘤和全身情况,选择合适的手术方法。

关键词: 肝内胆管细胞癌, 腹腔镜肝切除术, 开腹肝切除术, 治疗, 生存

Abstract: Objective The aim of this study was to compare the efficacy and safety of laparoscopic (LLR) and open liver resection (OLR) in the treatment of patients with intrahepatic cholangiocarcinoma (ICC). Methods 74 patients with ICC were enrolled in our hospital between January 2015 and June 2018, and 32 patients received LLR and 42 underwent OLR. All patients in the two groups were followed-up for 3 years. Results There was no significant differences as respect to ages, gender, abdominal operation history, serum carbohydrate antigen 199 and carcinoembryonic antigen levels, nerve invasion, microvascular invasion, tumor low differentiation, tumor diameters and lymph node enlargement between the two groups (P>0.05); the intraoperative blood loss, surgical incision length, hepatic portal occlusion, postoperative hospital stay, percentages of blood transfusion and post-operational gastrointestinal function recovery in patients receiving LLR were 325(250, 475)ml, 5(3.5, 6.5)cm, 9 cases(28.1%), 7(5, 12)d, 2 cases(6.2%)and 2(2, 4)d, significantly different as compared to [500(375, 750)ml, 20.5(17.0, 25.0)cm, 31 cases(73.8%), 10(7, 15)d, 7 cases (16.7%) and 4(3, 6)d] in patients receiving OLR (P<0.05), while there were no significant differences in one-year (81.2% vs. 76.2%) and three year (46.8% vs. 33.3%) survivals between the two groups (P>0.05); no severe untoward effects post-operationally occurred in our series. Conclusion At present, the LLR might be an alternative option for patients with ICC, although the OLR is still underwent in some circumstances, so the surgeon could make choice based on the patients' conditions and the technical requirement.

Key words: Intrahepatic cholangiocarcinoma, Laparoscopic liver resection, Open liver resection, Therapy, Survival

周建, 陆旭, 朱岩举, 王庆元, 冯明明, 郭胜利. 腹腔镜与开腹肝切除术治疗肝内胆管细胞癌患者疗效与安全性研究[J]. 实用肝脏病杂志, 2022, 25(2): 275-278.

Zhou Jian, Lu Xu, Zhu Yanju, et al. Comparison of efficacy and safety of laparoscopic and open liver resection in the treatment of patients with intrahepatic cholangiocarcinoma[J]. Journal of Practical Hepatology, 2022, 25(2): 275-278.

参考文献

[1] Liu X, Yao J, Song L, et al. Local and abscopal responses in advanced intrahepatic cholangiocarcinoma with low TMB, MSS, pMMR and negative PD-L1 expression following combined therapy of SBRT with PD-1 blockade. J Immunother Cancer, 2019, 7(1):204.
[2] Zhang XF, Bagante F, Chen Q, et al. Perioperative and long-term outcome of intrahepatic cholangiocarcinoma involving the hepatic hilus after curative-intent resection: comparison with peripheral intrahepatic cholangiocarcinoma and hilar cholangiocarcinoma. Surgery, 2018, 163(5):1114-1120.
[3] 安澜, 冉显会, 郑荣寿, 等. 中国肝细胞癌和肝内胆管细胞癌临床诊疗情况比较研究.中国癌症防治杂志, 2021, 13(2): 126-132.
[4] Sha M, Jeong S, Xia Q. Analysis of liver resection versus liver transplantation on outcome of small intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma in the setting of cirrhosis. Liver Transpl, 2020, 26(9):1202-1203.
[5] Lu J, Li B, Li FY, et al. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated? Eur J Surg Oncol, 2019, 45(11):2173-2179.
[6] Li H, Hu B, ZhouZQ, et al. Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studies. World J Surg Oncol, 2015, 13:161.
[7] 闫加艳, 陈炜, 王坚, 等. 顺逆结合肝门显露法治疗侵犯肝门的肝内胆管细胞癌. 中华消化外科杂志, 2017, 16(4): 417-422.
[8] Kang SH, Choi Y, Lee W, et al. Laparoscopic liver resection versus open liver resection for intrahepatic cholangiocarcinoma: 3-year outcomes of a cohort study with propensity score matching. Surg Oncol, 2020, 33:63-69.
[9] Ratti F, Rawashdeh A, Cipriani F, et al. Intrahepatic cholangiocarcinoma as the new field of implementation of laparoscopic liver resection programs. A comparative propensity score-based analysis of open and laparoscopic liver resections. Surg Endosc, 2021, 35(4):1851-1862.
[10] Zhai ST, Liang X, Mao QJ, et al. A retrospective pilot study to examine the feasibility of real-time navigation for laparoscopic liver resections in intrahepatic cholangiocarcinoma using fusion indocyanine green fluorescence imaging. J Surg Oncol, 2020, 122(2):226-233.
[11] 中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗规范(2019年版). 中华消化外科杂志, 2020, 19(1): 1-20.
[12] 吴舟桥, 王琦, 石晋瑶, 等. 欧美国家胃癌手术并发症的诊断标准及风险评估. 中华胃肠外科杂志, 2017, 20(2): 135-139.
[13] 陈骏, 毛谅, 何健, 等. 第8版《美国癌症联合会肿瘤分期手册》肝内胆管细胞癌TNM分期解读. 中华消化外科杂志, 2017, 16(4):330-335.
[14] Balitzer D, Joseph NM, Ferrell L, et al. Immunohistochemical and molecular features of cholangiolocellular carcinoma are similar to well-differentiated intrahepatic cholangiocarcinoma. Mod Pathol, 2019, 32(10):1486-1494.
[15] Burt AD, Alves V, Bedossa P, et al. Data set for the reporting of intrahepatic cholangiocarcinoma, perihilar cholangiocarcinoma and hepatocellular carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology, 2018, 73(3):369-385.
[16] Lee W, Park JH, Kim JY, et al. Comparison of perioperative and oncologic outcomes between open and laparoscopic liver resection for intrahepatic cholangiocarcinoma. Surg Endosc, 2016, 30(11):4835-4840.
[17] Wu J, Han J, Zhang Y, et al. Safety and feasibility of laparoscopic versus open liverresection with associated lymphadenectomy for intrahepatic cholangiocarcinoma. Biosci Trends, 2020, 14(5):376-383.
[18] 陈泰安, 杨发才, 李梦, 等. 腹腔镜肝切除术治疗肝内胆管细胞癌的安全性及疗效分析. 中华肝胆外科杂志, 2021,27(7):485-488.
[19] Tan SY, Visvanathan S, Abu Hassan R, et al. Autophagic degradation of misfolded nuclear receptor co-repressor (NCoR) is linked to the growth of tumor cells in HBX positive hepatocellular carcinoma (HCC). Front Oncol, 2019,9:1335.
[20] Guerrini GP, Esposito G, Tarantino G, et al. Laparoscopic versus open liver resection for intrahepatic cholangiocarcinoma: the first meta-analysis. Langenbecks Arch Surg, 2020, 405(3):265-275.